Corrigendum to "Preclinical studies on new proteins as carrier for glycoconjugate vaccines" [Vaccine 34 (2016) 4235-4242]

Vaccine. 2017 May 2;35(19):2612. doi: 10.1016/j.vaccine.2017.03.011. Epub 2017 Mar 30.

Authors

M Tontini¹, M R Romano¹, D Proietti¹, E Balducci¹, F Micoli², C Balocchi¹, L Santini¹, V Masignani¹, F Berti¹, P Costantino³

Affiliations

¹ GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
² GSK Vaccines Institute for Global Health (GVGH) S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
³ GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy. Electronic address: paolo.x.costantino@gsk.com.

PMID: 28365250
DOI: 10.1016/j.vaccine.2017.03.011

No abstract available

Publication types

Published Erratum